UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A multi-center, open-label, single-arm, Phase 3b study of macitentan in patients with Pulmonary Arterial Hypertension to psychometrically validate the PAH-SYMPACT instrument
    Linda Cadaret
  2. A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated w
    Alexandra Thomas
  3. A Phase III, Multi-center, Open-label, Randomized, Controlled Study of the Efficacy and Safety of Oral LDE225 Versus Temozolomide in Patients With Hh-pathway Activated Relapsed Medulloblastoma
    Sue O
  4. Prospective Randomized Phase II Trial of Pazopanib (NSC #737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors
    Nancy Sharma
  5. PARACHUTE IV: Percutaneous Ventricular Restoration in Chronic Heart Failure due to Ischmic Heart Disease. A Pivotal Trial to Establish Efficacy and Long-term Safety of the Parachute implant system
    Vladamir Cotarlan
  6. Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans (INCITE)
    Gary L. Pierce
  7. Investigational Vaccine for Melanoma
    Mohammed Milhem
  8. A Phase 1b/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
    Daniel Vaena
  9. Combination of Chemotherapy Drugs for Women with HER2-Negative Breast Cancer
    Mark Karwal
  10. Effectiveness of the Drug BIBF 1120 in Treating Endometrial Cancer
    David Bender
  11. A Pilot Study of Longitudinal Communication Networks in Families at Risk of Colorectal Cancer
    Anne Ersig
  12. Study Researching Head and Neck Cancer
    Mohammed Milhem
  13. Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia
    Ayman El-Sheikh
  14. Factors Contributing to Low Screening Rates among Persons at Increased Risk for Colorectal Cancer
    Anne Ersig
  15. Study for Safety of the Drug Ruxolitnib
    Thomas Carter
  16. Effects of Vitamin D Replacement on Tumor Response and Survival Parameters
    Brian Link
  17. A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast…
    Alexandra Thomas
  18. Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carc…
    Daniel Vaena
  19. A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) versus IA with Vorinostat (IA+V) in Younger Patients with Previously Un…
    Thomas Carter
  20. A randomized, double-blind, placebo-controlled, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in the frontline treatment of patient with CD30-positive mature T-cell lymphomas: the A…
    Brian Link

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.